gain / (loss) from FX – Non-recurring income / (expense) KEY FINANCIAL HIGHLIGHT Sales and Service Income • Sales and service income increased 13.5% year- on-year from Baht 27,747 million in 2016 to Baht
) (149.44) 41.71 27.91% 6 Finance costs (14.56) (13.10) 1.46 11.15% Share of profit (loss) of associates (1.32) - 1.32 100.00% 7 Profit before income tax 104.50 78.33 26.17 33.41% Income tax (30.75) (19.28
52.93 -35.73% Financial expense (0.19) (0.73) (0.67) 252.63% -8.22% (0.49) (1.66) 238.78% Profit before income tax expense 12.77 18.36 16.27 27.41% -11.38% 81.87 51.27 -37.38% Income tax expense (2.74
Revenues 1,711.52 2,072.15 Selling & Administrative Expense 110.78 118.49 Finance Costs 27.51 20.44 Net Profit (12.84) (2.59) Earnings per share (Baht) (0.032) (0.007) The comparison between Third Quarter of
) Other Incomes 65.83 78.14 Total Revenues 7,922.87 7,879.44 Selling & Administrative Expense 494.47 507.94 Finance Costs 83.94 90.76 Net Profit 17.98 443.44 Earnings per share (Baht) 0.05 1.11 The company
share is Baht 0.69 per share, increased from last year that showed at Baht 0.55 per share. According to the company’s Board of Director’s meeting, the meeting had approved to pay interim dividend for the
increased from 84.8 million Baht of year 2018 due to marketing expense for export business. 4. Finance Cost was 18.94 million baht decreased from Year 2018 of 20.81 million Baht due to lower in borrowing and
proportion in this asset class. However, the Company recorded gain on sale of investment in listed equity securities of Baht 5.46 million in this quarter. The Company recognized share of profit from
amounting to Baht 29.10 million. However, if the Company did not have this expense, the profit of quarter 4 in 2018 will be more that the profit of the same period in 2017. For share of loss from investments
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and